{"id":"https://openalex.org/W4389799772","doi":"https://doi.org/10.57264/cer-2023-0108","title":"Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data","display_name":"Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data","publication_year":2023,"publication_date":"2023-12-15","ids":{"openalex":"https://openalex.org/W4389799772","doi":"https://doi.org/10.57264/cer-2023-0108","pmid":"https://pubmed.ncbi.nlm.nih.gov/38099519","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10842297"},"language":"en","primary_location":{"id":"doi:10.57264/cer-2023-0108","doi":"https://doi.org/10.57264/cer-2023-0108","is_oa":true,"landing_page_url":"https://doi.org/10.57264/cer-2023-0108","pdf_url":null,"source":{"id":"https://openalex.org/S2489859990","display_name":"Journal of Comparative Effectiveness Research","issn_l":"2042-6305","issn":["2042-6305","2042-6313"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Effectiveness Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.57264/cer-2023-0108","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083268234","display_name":"Julia A. Pisc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106950","display_name":"Aetion (United States)","ror":"https://ror.org/02efksf92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julia Pisc","raw_affiliation_strings":["Aetion Inc., New York, NY\u00a010001, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aetion Inc., New York, NY\u00a010001, USA","institution_ids":["https://openalex.org/I4210106950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013003874","display_name":"Angela Ting","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127098","display_name":"UCB Pharma (United States)","ror":"https://ror.org/028qka468","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127098","https://openalex.org/I85722119"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Angela Ting","raw_affiliation_strings":["UCB Pharma, Atlanta, GA\u00a030080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Atlanta, GA\u00a030080, USA","institution_ids":["https://openalex.org/I4210127098"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103139445","display_name":"Michelle Skornicki","orcid":"https://orcid.org/0000-0002-2594-2569","observed_orcids":["https://orcid.org/0000-0002-2594-2569","https://orcid.org/0000-0002-1776-7107"]},"institutions":[{"id":"https://openalex.org/I4210106950","display_name":"Aetion (United States)","ror":"https://ror.org/02efksf92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Skornicki","raw_affiliation_strings":["Aetion Inc., New York, NY\u00a010001, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aetion Inc., New York, NY\u00a010001, USA","institution_ids":["https://openalex.org/I4210106950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093508777","display_name":"Omar Sinno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127098","display_name":"UCB Pharma (United States)","ror":"https://ror.org/028qka468","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127098","https://openalex.org/I85722119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Omar Sinno","raw_affiliation_strings":["UCB Pharma, Atlanta, GA\u00a030080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Atlanta, GA\u00a030080, USA","institution_ids":["https://openalex.org/I4210127098"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100670406","display_name":"Edward Wolfgang Lee","orcid":"https://orcid.org/0000-0003-0418-1454","observed_orcids":["https://orcid.org/0000-0003-0418-1454"]},"institutions":[{"id":"https://openalex.org/I4210127098","display_name":"UCB Pharma (United States)","ror":"https://ror.org/028qka468","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127098","https://openalex.org/I85722119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Lee","raw_affiliation_strings":["UCB Pharma, Atlanta, GA\u00a030080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Atlanta, GA\u00a030080, USA","institution_ids":["https://openalex.org/I4210127098"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5013003874"],"corresponding_institution_ids":["https://openalex.org/I4210127098"],"apc_list":null,"apc_paid":null,"fwci":2.7478,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.9073375,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"13","issue":"1","first_page":"e230108","last_page":"e230108"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11538","display_name":"Ophthalmology and Eye Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myasthenia-gravis","display_name":"myasthenia gravis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/exacerbations","display_name":"exacerbations","score":0.734000027179718},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.9819999933242798},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.9919999837875366},{"id":"https://openalex.org/keywords/economic-burden","display_name":"economic burden","score":0.9110000133514404},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.8709999918937683},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":1.0},{"id":"https://openalex.org/keywords/medicare","display_name":"Medicare","score":0.5139999985694885},{"id":"https://openalex.org/keywords/private-insurance","display_name":"private insurance","score":0.8479999899864197},{"id":"https://openalex.org/keywords/medicaid","display_name":"Medicaid","score":0.7110000252723694},{"id":"https://openalex.org/keywords/disease-management","display_name":"disease management","score":0.6729999780654907}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9481595754623413},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.9128406047821045},{"id":"https://openalex.org/C2778105408","wikidata":"https://www.wikidata.org/wiki/Q8285","display_name":"Myasthenia gravis","level":2,"score":0.659837007522583},{"id":"https://openalex.org/C2776534028","wikidata":"https://www.wikidata.org/wiki/Q1141363","display_name":"Medicaid","level":3,"score":0.6367658972740173},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.6258531212806702},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4346274435520172},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4225746989250183},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3773784339427948},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003695","descriptor_name":"Delivery of Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006278","descriptor_name":"Medicare","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009157","descriptor_name":"Myasthenia Gravis","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.57264/cer-2023-0108","doi":"https://doi.org/10.57264/cer-2023-0108","is_oa":true,"landing_page_url":"https://doi.org/10.57264/cer-2023-0108","pdf_url":null,"source":{"id":"https://openalex.org/S2489859990","display_name":"Journal of Comparative Effectiveness Research","issn_l":"2042-6305","issn":["2042-6305","2042-6313"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Effectiveness Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10842297","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10842297","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10842297/pdf/cer-13-230108.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Comp Eff Res","raw_type":"Text"},{"id":"pmid:38099519","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38099519","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of comparative effectiveness research","raw_type":"Journal Article"},{"id":"pmh:oai:digitalcommons.library.tmc.edu:uthgsbs_docs-3148","doi":null,"is_oa":false,"landing_page_url":"https://digitalcommons.library.tmc.edu/uthgsbs_docs/2201","pdf_url":null,"source":{"id":"https://openalex.org/S4377196655","display_name":"Digital Commons-TMC (Texas Medical Center)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1337852284","host_organization_name":"Texas Medical Center","host_organization_lineage":["https://openalex.org/I1337852284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Faculty, Staff and Student Publications","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:893eec590ce048cabad9b785f6c00274","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/893eec590ce048cabad9b785f6c00274","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Comparative Effectiveness Research, Vol 13, Iss 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.57264/cer-2023-0108","doi":"https://doi.org/10.57264/cer-2023-0108","is_oa":true,"landing_page_url":"https://doi.org/10.57264/cer-2023-0108","pdf_url":null,"source":{"id":"https://openalex.org/S2489859990","display_name":"Journal of Comparative Effectiveness Research","issn_l":"2042-6305","issn":["2042-6305","2042-6313"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Effectiveness Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320337846","display_name":"UCB Pharma","ror":"https://ror.org/01n029866"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389799772.pdf","grobid_xml":"https://content.openalex.org/works/W4389799772.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1645572349","https://openalex.org/W1977231670","https://openalex.org/W2066020137","https://openalex.org/W2145644832","https://openalex.org/W2277245749","https://openalex.org/W2461303519","https://openalex.org/W2532256659","https://openalex.org/W2592227425","https://openalex.org/W2766784006","https://openalex.org/W2789644345","https://openalex.org/W2798123633","https://openalex.org/W2937473679","https://openalex.org/W3022091895","https://openalex.org/W3041450548","https://openalex.org/W3081724166","https://openalex.org/W3094785429","https://openalex.org/W3112836341","https://openalex.org/W3137694525","https://openalex.org/W3163978890","https://openalex.org/W3170470841","https://openalex.org/W3177737735","https://openalex.org/W4210959453","https://openalex.org/W4211188347","https://openalex.org/W4223943746","https://openalex.org/W4224868010","https://openalex.org/W4224989731","https://openalex.org/W4242174441","https://openalex.org/W4281771179","https://openalex.org/W4283322590","https://openalex.org/W4285028098","https://openalex.org/W4312157426","https://openalex.org/W4317904577","https://openalex.org/W4365456974","https://openalex.org/W4365457148"],"related_works":["https://openalex.org/W7092201021","https://openalex.org/W4206510546","https://openalex.org/W4409222380","https://openalex.org/W4389142085","https://openalex.org/W4404630906","https://openalex.org/W4317904577","https://openalex.org/W4404970633","https://openalex.org/W4409226638","https://openalex.org/W4312157426","https://openalex.org/W7222965587"],"abstract_inverted_index":{"Aim:":[0],"There":[1],"are":[2,238],"limited":[3],"data":[4],"on":[5],"the":[6,56,78,153],"clinical":[7,22,243],"and":[8,25,96,107,145,162,168,183,201,208,244,250,256,265],"economic":[9,245],"burden":[10,246],"of":[11,42,73,103,158,181,231],"exacerbations":[12,159,175,237,264],"in":[13,77,215,247],"patients":[14,44,63,185,216],"with":[15,31,45,111,186,217,225,240],"myasthenia":[16],"gravis":[17],"(MG).":[18],"We":[19],"assessed":[20],"patient":[21,164],"characteristics,":[23],"treatments":[24,106,233],"healthcare":[26,192],"resource":[27],"utilization":[28,230],"(HCRU)":[29],"associated":[30,110,239],"MG":[32,46,68,88,105,124,236],"exacerbation.":[33,101,188],"Patients":[34],"&":[35],"methods:":[36],"This":[37],"was":[38,165],"a":[39,116,241],"retrospective":[40],"analysis":[41],"adult":[43],"identified":[47],"by":[48,178],"commercial,":[49,135],"Medicare":[50,163,184,209,251],"or":[51,66,75],"Medicaid":[52],"insurance":[53],"claims":[54],"from":[55,197,202],"IBM":[57],"\u00ae":[58,60],"MarketScan":[59],"database.":[61],"Eligible":[62],"had":[64],"two":[65,174],"more":[67],"diagnosis":[69],"codes,":[70],"without":[71],"evidence":[72],"exacerbation":[74,112,132,195],"crisis":[76],"baseline":[79,95],"period":[80],"(12":[81],"months":[82],"prior":[83],"to":[84,199,204,262],"index":[85],"[first":[86],"eligible":[87],"diagnosis]).":[89],"Clinical":[90],"characteristics":[91],"were":[92,113,176],"evaluated":[93],"at":[94],"12":[97],"weeks":[98],"before":[99],"each":[100],"Number":[102],"exacerbations,":[104,219],"HCRU":[108],"costs":[109,193],"described":[114],"during":[115],"2-year":[117],"follow-up":[118],"period.":[119],"Results:":[120],"Among":[121],"9352":[122],"prevalent":[123],"patients,":[125,210],"34.4%":[126],"(n":[127,137,142,148],"=":[128,138,143,149],"3218)":[129],"experienced":[130,177],"\u22651":[131,187],"after":[133],"index:":[134],"53.0%":[136],"1706);":[139],"Medicare,":[140],"39.4%":[141],"1269);":[144],"Medicaid,":[146],"7.6%":[147],"243).":[150],"During":[151],"follow-up,":[152],"mean":[154],"(standard":[155],"deviation)":[156],"number":[157],"per":[160,194],"commercial":[161,182,207,249],"3.7":[166],"(7.0)":[167],"2.7":[169],"(4.1),":[170],"respectively.":[171,211],"At":[172],"least":[173],"approximately":[179],"half":[180],"Mean":[189],"total":[190],"MG-related":[191],"ranged":[196],"$26,078":[198],"$51,120,":[200],"$19,903":[203],"$49,967":[205],"for":[206,234],"AChEI":[212],"use":[213,223],"decreased":[214],"multiple":[218,226],"while":[220],"intravenous":[221],"immunoglobulin":[222],"increased":[224],"exacerbations.":[227],"Conclusion:":[228],"Despite":[229],"current":[232],"MG,":[235],"high":[242],"both":[248],"patients.":[252],"Additional":[253],"treatment":[254],"options":[255],"improved":[257],"disease":[258,266],"management":[259],"may":[260],"help":[261],"reduce":[263],"burden.":[267]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-12-16T00:00:00"}